Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-150 for Acute Pain Following Bunionectomy
NCT03206749Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jun 2017
- Primary completion
- Dec 2017
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VX-150 in acute pain (3 arms), sponsored by Vertex Pharmaceuticals. Primary endpoint: Time-weighted Sum of the Pain Intensity Difference 0 to 24 Hours. Started Jun 2017; status: completed.
02
Drugs
VX-150
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03206749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03206749.